A blood atlas of COVID-19 defines hallmarks of disease severity and specificityDavid Ahern, Hal Drakesmith, G. Berridge et al.|Cell|2022Cited by 327
High-throughput mass spectrometry maps the sepsis plasma proteome and differences in patient responseYuxin Mi, Marie McCauley, G. Berridge et al.|Science Translational Medicine|2024Cited by 55
A blood atlas of COVID-19 defines hallmarks of disease severity and specificityDavid Ahern, Susanna Dunachie, Andrew Brent et al.|medRxiv|2021Cited by 35
High-throughput mass spectrometry maps the sepsis plasma proteome and differences in responseYuxin Mi, Julian C. Knight, G. Berridge et al.|medRxiv|2022Cited by 5